Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Chiesi to acquire KalVista Pharmaceuticals

Lucid Diligence Brief: Chiesi to acquire KalVista Pharmaceuticals Professional…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Teva to acquire Emalex Biosciences

Lucid Diligence Brief: Teva to acquire Emalex Biosciences Professional…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Coultreon Biopharma Raises $125M for SIK3 Inhibitor

Lucid Diligence Brief: Coultreon Biopharma Raises $125M for SIK3 Inhibitor…


Lucid Diligence Brief - Tech

Lucid Diligence Brief: Profluent-Lilly AI-Designed Recombinase Partnership

Lucid Diligence Brief: Profluent-Lilly AI-Designed Recombinase Partnership…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Lilly to acquire Ajax Therapeutics

Lucid Diligence Brief: Lilly to acquire Ajax Therapeutics Professional…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Cantargia nadunolimab in MDS and AML

Lucid Diligence Brief: Cantargia nadunolimab in MDS and AML Professional…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Sun Pharma acquisition of Organon

Lucid Diligence Brief: Sun Pharma acquisition of Organon Professional audiences…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Regeneron Otarmeni FDA approval

Lucid Diligence Brief: Regeneron Otarmeni FDA approval Professional audiences…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Avalyn Pharma IPO

Lucid Diligence Brief: Avalyn Pharma IPO Professional audiences only. Not…


Lucid Diligence Brief - Tech

Lucid Diligence Brief: Merck × Google Cloud agentic AI partnership

Lucid Diligence Brief: Merck × Google Cloud agentic AI partnership Professional…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Tortugas Neuroscience launches with $106 million financing

Lucid Diligence Brief: Tortugas Neuroscience launches with $106 million…


Privacy Preference Center